MFIM
OPRX icon

Mesirow Financial Investment Management’s OptimizeRx OPRX Stock Holding History

Mesirow Financial Investment Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,006
Closed -$219K – 74
2022
Q2 		$219K Sell
8,006
-21
-0.3% -$622 1.06% 62
2022
Q1 		$303K Buy
+8,027
New +$355K 1.02% 64

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Mesirow Financial Investment Management's OPRX Position: Q3 2022 in Review

Mesirow Financial Investment Management sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 8,006 shares — an estimated $219K sold.

Mesirow Financial Investment Management first reported a position in OPRX in Q1 2022 and held it in 2 quarters. The position peaked at $303K in Q1 2022. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • Mesirow Financial Investment Management reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 8,006 OptimizeRx shares in Q3 2022, an estimated $219K.
  • Mesirow Financial Investment Management first reported a position in OptimizeRx in Q1 2022 and held it in 2 quarters.
  • Mesirow Financial Investment Management's OptimizeRx position peaked at $303K in Q1 2022.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q3 2022, filed 26 Oct 2022.